Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits

Area of Science:

• Cardiovascular Research
• Nutritional Science
• Molecular Biology

Background:

• Atherosclerosis is linked to oxidized low-density lipoprotein (oxLDL) uptake by scavenger receptors like CD36.
• Foam cell formation, driven by oxLDL accumulation in macrophages, is a key pathological event in atherosclerosis.
• The precise mechanism of Vitamin E's preventive role in atherosclerosis remains incompletely understood.

Purpose of the Study:

• To investigate the in vivo effect of Vitamin E on CD36 scavenger receptor expression in a rabbit model of atherosclerosis.
• To determine if Vitamin E can prevent cholesterol-induced atherosclerotic lesions and associated changes in CD36 mRNA levels.

Main Methods:

• Atherosclerosis was induced in rabbits using a cholesterol-rich, Vitamin E-deficient diet.
• Rabbits were divided into three groups: control (Vitamin E-deficient diet), cholesterol-fed, and cholesterol-fed with Vitamin E supplementation.
• Aortic tissues were analyzed for atherosclerotic lesions via light microscopy and for CD36 mRNA expression.

Main Results:

• Cholesterol feeding induced significant atherosclerotic lesions and increased CD36 mRNA expression in rabbit aortas.
• Vitamin E supplementation completely prevented the development of atherosclerotic lesions.
• Vitamin E treatment also normalized the elevated CD36 mRNA expression observed in cholesterol-fed rabbits.

Conclusions:

• Vitamin E exhibits a protective effect against atherosclerosis in vivo.
• The mechanism involves the downregulation of CD36 scavenger receptor expression, thereby reducing foam cell formation.
• These findings highlight Vitamin E's potential as a therapeutic agent in managing atherosclerosis.